A recent DaVita lawsuit alleges the company misled patients about the risks of a blood clotting medication. The drug, GranuFlo, was recalled by the U.S. Food and Drug Administration due to an excess of acetate. Defendants’ products contain excess acetate, which can lead to metabolic alkalosis and an increased risk of stroke. The lawsuit also claims that DaVita failed to adequately inspect the product, leading to injuries and deaths.
- 1 The plaintiff, who is six months pregnant, alleged that DaVita terminated her without a just cause.
The plaintiff, who is six months pregnant, alleged that DaVita terminated her without a just cause.
She was about to take maternity leave when she was terminated. She claimed that DaVita terminated her employment because she was about to use FMLA leave that was related to her pregnancy. This termination was unlawful, and she argues that it violated the New York City and State Human Rights Laws. She is seeking damages and a declaratory judgment. Crumiller P.C. is representing her.
The plaintiff claims that her employment was terminated without cause. She was six months pregnant at the time of her termination and likely to take maternity leave. The company claimed that the termination was an attempt to prevent her from taking extended FMLA leave. This action was also illegal. The employee believes that the termination violated the rights of women and was in violation of New York City and State human rights laws. During the eight months she worked on the evening shift, she complained to her manager. She returned to work on her regular schedule in April 2018. She continued working at DaVita and received positive evaluations from her supervisors.
The DaVita lawsuit claims that the company conspired with Thiry to suppress competition in the dialysis industry.
The company allegedly steered patients away from the competing dialysis provider in exchange for higher reimbursement rates. The companies agreed not to solicit each other’s, senior-level employees. The suit also claims that the companies misled investors. These executives deny any wrongdoing. The case is pending in California.
The company allegedly engaged in collusion with Thiry to compel employees to continue working at DaVita. The two companies allegedly agreed not to solicit each other’s, senior-level employees. In addition, both companies alleged that they were prohibited from communicating with each other. A jury-judged decision has not yet been made. The case, however, will last for a long time. The trial will last for years and will be determined by how much the plaintiff can recover from the company.
While the company disputed these claims, the settlement was worth $400 million, which is the largest ever in the healthcare industry. The case was filed by a whistleblower who worked in the mergers and acquisitions department at DaVita. But he eventually left the company because of concerns about financial transactions. The lawsuit is currently pending in court.
The company aims to settle the lawsuit by paying an additional $400 million to the whistleblower. The plaintiff, a former employee of DaVita, argued that the company allegedly paid doctors hidden kickbacks to influence their decisions. In exchange, he was forced to accept the payment and subsequently resigned from his job. As a result, he has been unable to work since then. He was forced to work from home after his employer refused to give him paid maternity leave.
In addition to the lawsuit, the company is also facing a federal investigation.
In October 2017, the government sent DaVita a subpoena for information related to a pending class action. The defendants acknowledge the subpoena, but they deny any illegal actions by the company. The companies are accused of illegally funneling money to a nonprofit organization to reimburse patients’ health premiums. This would be a breach of the law and could lead to a fine for the company.
During the investigation, the company found that the allegations against DaVita’s senior executives were true and that it was an illegal practice. The company also admitted that it had taken steps to avoid the claims. The lawsuit states that the executives of DaVita knew about the “scheme” when they terminated the employees. The attorneys also denied any wrongdoing and were unable to prove that the allegations were unfounded.